Sympathoinhibitory function of the α( 1/2 A)-adrenergic receptor subtype

Hypertension

Volumn 34, Issue 3, 1999, Pages 403-407

  Makaritsis, Konstantinos P ^a   Johns, Conrado ^a   Gavras, Irene ^a   Altman, John D ^a,b   Handy, Diane E ^a   Bresnahan, Margaret R ^a   Gavras, Haralambos ^a  

^a BOSTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b STANFORD UNIVERSITY   (United States)

Author keywords

Adrenergic receptors; Hyperadrenergic state; Hypertension, sodium dependent; Mice, knockout

Indexed keywords

ALPHA 2 ADRENERGIC RECEPTOR;

ADRENERGIC SYSTEM; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BLOOD PRESSURE REGULATION; CONTROLLED STUDY; HYPERTENSION; KNOCKOUT MOUSE; NONHUMAN; PRESSORECEPTOR REFLEX; PRIORITY JOURNAL; RECEPTOR INTRINSIC ACTIVITY; SALT LOADING; SYSTOLIC BLOOD PRESSURE;

EID: 0032886791     PISSN: 0194911X     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.HYP.34.3.403     Document Type: Article

References (19)

1. Gavras H. How does salt raise BP? A hypothesis. Hypertension. 1986;8: 83-88.
2. Gavras H, Gavras I. Salt-induced hypertension: the interactive role of vasopressin and of the sympathetic nervous system. J Hypertens. 1989; 7:601-606.
3. 2-adrenoceptor agonist function. J Hypertens. 1985;3:269-274.
4. 2-adrenergic receptors in spontaneously hypertensive rats. Hypertension. 1988;11:326-333.
5. 2-adrenoceptors in SHR. Brain Res. 1988;451:77-84.
6. Tsai BS, Lefkowitz J. Agonist-specific effects of monovalent and divalent cations on adenylate cyclase-coupled alpha adrenergic receptors in rabbit platelets. Mol Pharmacol. 1978;14:540-548.
7. Bresnahan MR, Gavras I, Hatinoglou S, Muller RE, Gavras H. Central α-adrenoceptors during the development of hypertension in rats on high-and low-salt intake. J Hypertens. 1986;4:719-726.
8. 2C-adrenoceptor homology. Mol Pharmacol. 1995;48:48-55.
9. 2-adrenergic receptor subtypes b and c. Science. 1996;273:803-805.
10. 2B-adrenergic receptor in the development of salt-induced hypertension. Hypertension. 1999;33:14-17.
11. Johns C, Gavras I, Handy DE, Salomao A, Gavras H. Models of experimental hypertension in mice. Hypertension. 1996;28:1064-1069.
12. Onesti G, Schwartz AM, Kim KE, Schwartz C, Brest AN. Pharmacodynamic effects of a new antihypertensive drug, Catapress (ST-155). Circulation. 1969;39:219-228.
13. 2a-adrenergic receptor subtype. Science. 1996; 273:801-803.
14. 2-adrenoceptor-subtype function. Trends Pharmacol Sci. 1997;18:211-219.
15. 2B-adrenergic receptor subtypes in brain. Hypertension. 1996;27(pt 1):449-455.
16. Hökfelt T, Fuxe K, Goldstein M, Johansson O. Evidence of adrenaline neurons in the rat brain. Acta Physiol Scand. 1973;89:286-288.
17. Nathan MA, Reis DJ. Chronic labile hypertension produced by lesion of the nucleus tractus solatarii in the cat. Circ Res. 1977;40:72-81.
18. Gavras H, Bain GT, Bland L, Vlahakos D, Gavras I. Hypertensive response to saline microinjection in the area of the nucleus tractus solitarii of the rat. Brain Res. 1985;343:113-119.
19. 2A-adrenergic receptor knockout mice. Mol Pharmacol. 1999;56:154-161.